---
layout: page
permalink: /publications/index.html
title: Publications
---

> (†: equal contribution, ~: corresponding author)

## Publication (First author/Co-first author)

- [**Comparative therapeutic efficacy and safety of first-line and second-line therapies for metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis**](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00061-6/fulltext)<br>[*eClinical Medicine*]           (Q1) Impact Factor = **<font color="#990000">10.0</font>**<br>***Bohao Jiang***†, Benqiao Wang†, Yiming Chen, Yaang Chen，Bohan Li~, Jianbin Bi~<br>PMID: 40104085                                       doi: 10.1016/j.eclinm.2025.103129 

-  [**Early Predictive Accuracy of Machine Learning for Hemorrhagic Transformation in Acute Ischemic Stroke: A Systemic review and Meta-Analysis**](https://www.jmir.org/2025/1/e71654)

  [*J Medical Internet Res.*]          (Q1) Impact Factor = **6.0**<br>

  Benqiao Wang†, ***Bohao Jiang***†, Dan Liu, Ruixia Zhu~<br>

  PMID: 40408765                                       doi: 10.2196/71654<br>

  Contribution: Data analysis and statistical method support<br>

- [ **Retroperitoneal Bronchogenic Cyst：A Case Report and Literature review**](https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1406270/full)<br>[*Frontiers in Oncology*]         (Q2) Impact Factor = **3.3**<br>***Bohao Jiang***†, Tiantian Xie†, Jiyuan Hu†, Yitong Xu~, Hao Zhang~<br>PMID: 35944288                                        doi:  10.3389/fonc.2024.1406270<br>

- [**Two Rare Cases of Primary Clear Cell Adenocarcinoma of the Urethra: Clinical experience, Case report and Literature Review**](https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1539312/full)<br>[*Frontiers in Oncology*]         (Q2) Impact Factor = **3.3**<br>***Bohao Jiang***†, Jiyuan Hu†, Benqiao Wang, Xujia Liu~, Yitong Xu~, Hao Zhang~<br>PMID: 40012547                             doi: 10.3389/fonc.2025.1539312<br>

- [**Case Report: Two Cases of Chemotherapy Refractory Aggressive Variant Prostate Cancer with Extreme Durable Response to PARP inhibitor**](https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1533627/full)<br>

  [*Frontiers in Oncology*]         (Q2) Impact Factor = **3.3**<br>

  ***Bohao Jiang***†, Yifan Bi†, Yiming Chen, Jianbin Bi, Jian Deng~, Gejun Zhang~<br>

  PMID: 40342821                                          doi: 10.3389/fonc.2025.1533627<br>

---

## **MANUSCRIPTS UNDER REVIEW** 

(1) **Constructing a dual-model diagnostic framework for clinically significant prostate cancer using multi-parameter magnetic resonance imaging, biochemical testing, and prostate health index**  <br>

***Bohao Jiang***†, Shouzhen Chen†, Xianhao Xiao†, Jiyuan Hu†, Jianbin Bi~*, Jianfeng Wang~*, Hao Zhang~<br>

Contribution: Writing, Clinical data collection, Data analysis, Main organizer<br>

(2) **4 cases of Juxtaglomerular cell tumor: Clinical experience and literature review**<br>

Mingyue Jin†, ***Bohao Jiang***†, Jiyuan Hu†, Xianhao Xiao, Xiaolong Hou, Xiaoxiao Xu, Xiaojun Man~, Hao Zhang~<br>

Contribution: Clinical data collection<br>(3) **Transforming Cancer Care: How Multi-modal Data and Machine Learning Enhance Prognosis for High-Risk Prostate Cancer Patients post RARP - A Multi-Center Retrospective Study**<br>

Jiyuan Hu†, Qi Miao†, Jiayi Ren†, ***Bohao Jiang***†, Moyu Xia, Yi Jing, Wangmin Liu, Yiming Chen, Xianhao Xiao, Ruimei Chai, Yuan Miao, Guangtai Liang, Dongli Feng, Mo Zhang ~, Jianbin Bi~<br>

Contribution: Clinical data collection & Idea communication<br>
